| Bioactivity | Enuzovimab is an anti-SARS-CoV-2 human?IgG4?κ monoclonal antibody[1]. Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003). |
| Target | SARS-CoV-2 |
| CAS | 2531098-91-4 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Enuzovimab |